The number of new pharmaceutical companies being set up in Russia is steadily declining due to sanctions and the ever-growing ...

California’s Gate Bioscience, a biotech developing molecular gates, a new class of small molecule drugs to eliminate ...

UK pharma major AstraZeneca is preparing to advance gefurulimab as a potential new treatment for generalized myasthenia ...

US biotech Avidity Biosciences’ stock rose 4% on Wednesday after the company announced that the US Food and Drug ...

Privately-held Danish dermatology specialist LEO Pharma today revealed that the US Food and Drug Administration (FDA) has ...

A new report has drawn attention to the growing number of prescription drugs being excluded from commercial insurance ...

The US Food and Drug Administration (FDA) has extended the review period for the Biologics License Application (BLA) for ...

Hospitals are rationing cancer treatments. Pharmacies are scrambling to fill routine antibiotic prescriptions. And across the USA, patients are facing growing delays, substitutions, or outright ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved US pharma major AbbVie’s Elahere (mirvetuximab soravtansine) to treat adults with ovarian cancer, fallopian tube ...

Italian family-owned drugmaker Chiesi Farmaceutici and Switzerland’s Serna Bio today announced a global drug discovery and ...

Australian venture capital firm Brandon Capital has closed its largest fund to date, raising A$439 million ($296 million) for its sixth life sciences fund. The final close brings in new government ...

China remains the most popular country for clinical trials outside North America and Europe in the second quarter (Q2) of 2025, according to a report by the data and analytics company GlobalData.